Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) EBT Margin (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed EBT Margin for 10 consecutive years, with 54603.23% as the latest value for Q1 2025.

  • On a quarterly basis, EBT Margin changed N/A to 54603.23% in Q1 2025 year-over-year; TTM through Sep 2025 was 99356.8%, a 5101152.0% decrease, with the full-year FY2024 number at 49940.74%, up 879897.0% from a year prior.
  • EBT Margin was 54603.23% for Q1 2025 at Creative Medical Technology Holdings, up from 61802.47% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1786.07% in Q3 2022 to a low of 61802.47% in Q4 2024.
  • A 5-year average of 28379.35% and a median of 24232.53% in 2023 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: skyrocketed 21496579bps in 2021, then tumbled -2769778bps in 2022.
  • Creative Medical Technology Holdings' EBT Margin stood at 5719.92% in 2021, then plummeted by -484bps to 33417.7% in 2022, then crashed by -67bps to 55952.47% in 2023, then decreased by -10bps to 61802.47% in 2024, then rose by 12bps to 54603.23% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's EBT Margin are 54603.23% (Q1 2025), 61802.47% (Q4 2024), and 19471.6% (Q2 2024).